Correlation Between Black Diamond and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Black Diamond and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Amylyx Pharmaceuticals.
Diversification Opportunities for Black Diamond and Amylyx Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Black and Amylyx is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Black Diamond i.e., Black Diamond and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Black Diamond and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 1.57 times more return on investment than Amylyx Pharmaceuticals. However, Black Diamond is 1.57 times more volatile than Amylyx Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 214.00 in Black Diamond Therapeutics on November 2, 2024 and sell it today you would earn a total of 38.00 from holding Black Diamond Therapeutics or generate 17.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Black Diamond Therapeutics vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Black Diamond Therap |
| Amylyx Pharmaceuticals |
Black Diamond and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Black Diamond and Amylyx Pharmaceuticals
The main advantage of trading using opposite Black Diamond and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |